Global Amifostine Supply, Demand and Key Producers, 2026-2032
Description
The global Amifostine market size is expected to reach $ 62.87 million by 2032, rising at a market growth of 2.1% CAGR during the forecast period (2026-2032).
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. In 2024, global Amifostine production reached approximately 4.68 M unit, with an average global market price of around US$ 22 per unit.
The amifostine market is primarily shaped by its role as a cytoprotective agent used alongside chemotherapy and radiotherapy to reduce toxic side effects such as xerostomia and myelosuppression. Its clinical application is most notable in cancer care, particularly for head and neck cancers, though off-label exploration in other areas has also contributed to steady demand. The growing incidence of cancer worldwide, coupled with the rising adoption of supportive care therapies, supports market expansion. Additionally, increasing awareness of treatment-related quality-of-life issues and hospital protocols emphasizing patient safety have sustained the relevance of amifostine in oncology.
At the same time, the market faces headwinds from high treatment costs, limited availability in some regions, and the emergence of alternative protective agents or treatment regimens with fewer side effects. Patent expiries and the entry of generics have led to greater price competition, particularly in emerging markets where affordability drives uptake. Opportunities lie in expanding access through generics, advancing formulations to reduce adverse reactions such as hypotension and nausea, and integrating amifostine into broader supportive oncology care strategies. Overall, while niche compared to mainstream oncology drugs, the amifostine market remains stable, supported by its unique protective benefits in cancer treatment.
This report studies the global Amifostine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Amifostine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Amifostine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Amifostine total production and demand, 2021-2032, (K Units)
Global Amifostine total production value, 2021-2032, (USD Million)
Global Amifostine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Amifostine consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Amifostine domestic production, consumption, key domestic manufacturers and share
Global Amifostine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Amifostine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Amifostine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Amifostine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma, Mingren Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Amifostine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Amifostine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Amifostine Market, Segmentation by Type:
400mg/Dose
500mg/Dose
Global Amifostine Market, Segmentation by Application:
Head and Neck Cancer Adjuvant Therapy
Others
Companies Profiled:
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Key Questions Answered:
1. How big is the global Amifostine market?
2. What is the demand of the global Amifostine market?
3. What is the year over year growth of the global Amifostine market?
4. What is the production and production value of the global Amifostine market?
5. Who are the key producers in the global Amifostine market?
6. What are the growth factors driving the market demand?
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. In 2024, global Amifostine production reached approximately 4.68 M unit, with an average global market price of around US$ 22 per unit.
The amifostine market is primarily shaped by its role as a cytoprotective agent used alongside chemotherapy and radiotherapy to reduce toxic side effects such as xerostomia and myelosuppression. Its clinical application is most notable in cancer care, particularly for head and neck cancers, though off-label exploration in other areas has also contributed to steady demand. The growing incidence of cancer worldwide, coupled with the rising adoption of supportive care therapies, supports market expansion. Additionally, increasing awareness of treatment-related quality-of-life issues and hospital protocols emphasizing patient safety have sustained the relevance of amifostine in oncology.
At the same time, the market faces headwinds from high treatment costs, limited availability in some regions, and the emergence of alternative protective agents or treatment regimens with fewer side effects. Patent expiries and the entry of generics have led to greater price competition, particularly in emerging markets where affordability drives uptake. Opportunities lie in expanding access through generics, advancing formulations to reduce adverse reactions such as hypotension and nausea, and integrating amifostine into broader supportive oncology care strategies. Overall, while niche compared to mainstream oncology drugs, the amifostine market remains stable, supported by its unique protective benefits in cancer treatment.
This report studies the global Amifostine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Amifostine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Amifostine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Amifostine total production and demand, 2021-2032, (K Units)
Global Amifostine total production value, 2021-2032, (USD Million)
Global Amifostine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Amifostine consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Amifostine domestic production, consumption, key domestic manufacturers and share
Global Amifostine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Amifostine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Amifostine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Amifostine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma, Mingren Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Amifostine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Amifostine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Amifostine Market, Segmentation by Type:
400mg/Dose
500mg/Dose
Global Amifostine Market, Segmentation by Application:
Head and Neck Cancer Adjuvant Therapy
Others
Companies Profiled:
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Key Questions Answered:
1. How big is the global Amifostine market?
2. What is the demand of the global Amifostine market?
3. What is the year over year growth of the global Amifostine market?
4. What is the production and production value of the global Amifostine market?
5. Who are the key producers in the global Amifostine market?
6. What are the growth factors driving the market demand?
Table of Contents
109 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
